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ABSTRACT Oral epithelial cells monitor microbiome composition and initiate immune
response upon dysbiosis, as in the case of Candida imbalances. Candida species, such
as C. albicans and C. parapsilosis, are the most prevalent yeasts in the oral cavity.
Comparison of healthy oral epithelial cell responses revealed that while C. albicans
infection robustly activated inflammation cascades, C. parapsilosis primarily activated
various inflammation-independent pathways. In posttranscriptional regulatory proc-
esses, several miRNAs were altered by both species. For C. parapsilosis, the dose of
yeast cells directly correlated with changes in transcriptomic responses with higher fun-
gal burdens inducing significantly different and broader changes. MicroRNAs (miRNAs)
associated with carbohydrate metabolism-, hypoxia-, and vascular development-related
responses dominated with C. parapsilosis infection, whereas C. albicans altered miRNAs
linked to inflammatory responses. Subsequent analyses of hypoxia-inducible factor 1a
(HIF1-a) and hepatic stellate cell (HSC) activation pathways predicted target genes
through which miRNA-dependent regulation of yeast-specific functions may occur,
which also supported the observed species-specific responses. Our findings suggest
that C. parapsilosis is recognized as a commensal at low doses by the oral epithelium;
however, increased fungal burden activates different pathways, some of which overlap
with the inflammatory processes robustly induced by C. albicans.
IMPORTANCE A relatively new topic within the field of immunology involves the role
of miRNAs in innate as well as adaptive immune response regulation. In recent years,
posttranscriptional regulation of host-pathogenic fungal interactions through
miRNAs was also suggested. Our study reveals that the distinct nature of human oral
epithelial cell responses toward C. parapsilosis and C. albicans is possibly due to spe-
cies-specific fine-tuning of host miRNA regulatory processes. The findings of this
study also shed new light on the nature of early host cell transcriptional responses
to the presence of C. parapsilosis and highlight the species’ potential inflammation-
independent host activation processes. These findings contribute to our better
understanding of how miRNA deregulation at the oral immunological barrier, in non-
canonical immune cells, may discriminate between fungal species, particularly
Candida species with high or low pathogenic potential.
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The barrier function of epithelium is of paramount importance in maintaining home-ostasis and protecting hosts against an array of injuries, including from microbes.
Besides providing physical protection, cells of the epithelium produce and secrete vari-
ous enzymes (e.g., lysozymes), peptides (e.g., defensins), and other small molecules
(e.g., free oxygen radicals) that inhibit or kill diverse microbes (1). Epithelial cells also
actively contribute to innate immune responses (2). Opportunistic pathogenic Candida
species are members of the normal human mucosal microflora of the oral cavity, airways,
intestinal tract, and genitals (3). These species primarily cause infections in immunosup-
pressed patients or individuals with disrupted barrier functions (4). When Candida cells
are able to avoid or subvert host responses, serious and persistent local or systemic infec-
tions can arise (collectively also referred to as candidiasis), which includes life-threatening
invasive infections (5). The most common species associated with systemic invasive candi-
diasis is Candida albicans, although the occurrence of non-albicans Candida (NAC) species
has risen sharply in recent years, and invasive infections from NAC species are more fre-
quent than C. albicans in many geographical regions (6, 7).
One of the most common forms of candidiasis is oral candidiasis, which is primarily
caused by C. albicans, followed by C. glabrata, C. parapsilosis, C. tropicalis, and C. pseu-
dotropicalis (8). All of these species may be present in the healthy oral mycobiome;
however, their amount and diversity increase upon dysbiosis due to inflammation or
cancer (9, 10). These conditions also significantly increase the risk of developing oral
candidiasis. Recent cohort studies suggest that oral candidiasis occurs in ;32% of
organ transplant patients (11), ;36% of diabetic patients (12), 55% of patients with
radiation-induced stomatitis (13), and ;3% to 88% of individuals infected with HIV
(depending on their immune status), depending on the geographical location (14).
Interactions between oral epithelial cells (ECs) and C. albicans are widely studied. In
C. albicans, the most important step of the commensal-to-pathogen conversion is the
yeast-to-hypha morphology shift. Hypha-associated proteins enable the fungus to ac-
quire trace elements (e.g., iron) from ECs, attach to host cells, and invade through the
epithelial barrier via induced endocytosis or active penetration (15, 16). Once adhered
to the host’s surface, fungal cells are recognized mainly by Toll-like receptors and C-
type lectin receptors, which activate various signaling pathways (NF-κB and mitogen-
activated protein kinase [MAPK] signaling). Epithelial damage also occurs, due to the
secretion of various fungal enzymes or toxins, including candidalysin (17). As a result, a
shift in the host biphasic MAPK signaling occurs, which discriminates between the
commensal and pathogenic states of C. albicans (18). In contrast, relatively little is
known about EC responses to NAC species, such as C. parapsilosis. This is important as
the pathobiologies of these two species are extremely different. For example, C. albi-
cans elicits an almost immediate and vigorous proinflammatory host responses, while
the response evoked by C. parapsilosis is mild and delayed (19).
The milieu of the colonization site also seems to greatly influence the host response
toward these species, given the following previous findings. (i) In contrast with C. albi-
cans, C. parapsilosis is a common natural commensal of the human skin (20, 21). (ii) C.
parapsilosis infrequently causes oral candidiasis (22, 23). One possible explanation for
the markedly different host responses may be due to differences in posttranscriptional
regulatory processes. MicroRNAs (miRNAs) are important players in fine-tuning the
expression of genetic information. Recent studies demonstrate several pathogen-asso-
ciated molecular pattern (PAMP)-inducible miRNAs as well as miRNAs activated by Toll-
like receptor (TLR) signaling, such as miR-155, miR-132, miR-125b, or miR-146a (24),
that exhibited altered expression upon bacterial or viral induction (25). Despite their
confirmed relevance in host-pathogen interactions, only a few studies have analyzed
miRNA profiles of host cells following C. albicans exposure. According to these investi-
gations, miR-146 expression was significantly increased following b-glucan (a cell wall
component of C. albicans cells) treatment in THP-1 cells, which resulted in the inhibi-
tion of the proinflammatory response (26). Heat-killed C. albicans cells were found to
increase expression of five miRNAs in macrophages, including miR-155 and miR-146a,
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and the changes were induced by the activation of NF-κB signaling (27). In terms of
epithelial barriers, the presence of Candida-reactive miRNAs has also been reported in
airway ECs where several miRNA species associated with, for example, cell division, ap-
optosis, and differentiation processes, were identified (28).
In this study, we aimed to investigate how healthy oral ECs discriminate between C.
albicans and C. parapsilosis and to dissect the potential underlying discriminatory
mechanisms of the detected host responses. We further sought to examine whether
species-specific posttranscriptional regulatory processes controlled the phenomenon
by performing in-depth in silico analyses of both transcriptomic and miRNA sequenc-
ing data.
RESULTS
Robust antifungal humoral response is triggered by C. albicans, but not C.
parapsilosis in oral epithelial cells. In contrast with other innate immune cells, direct
cellular responses, such as pathogen internalization and subsequent killing, are not a
major function of ECs. The function of ECs manifests in the activation of professional
phagocytic cells through the secretion of chemokines, cytokines, or other signaling
molecules. Additional responses include the secretion of antimicrobial peptides, such
as beta-defensins, another route to effectively combat invading pathogens (29, 30). To
investigate the nature of healthy oral epithelial humoral responses to C. albicans and C.
parapsilosis, OKF6/TERT2 cells were used. We first examined the host cell damaging
capacity of both yeast species (Fig. 1A). For subsequent analyses, infection doses were
selected that did not exceed 25% of host cell damage. For C. albicans, the multiplicity
of infection (MOI) of 1:1 met this criterion (22.09%6 3.23%), while none of the applied
C. parapsilosis doses resulted in a more than 10% of host cell loss. Therefore, we
FIG 1 Epithelial response activation by C. albicans and C. parapsilosis. OKFT6/TERT2 cells were cultured with C. albicans (Ca) or C. parapsilosis
(Cp) in different infection ratios to investigate their host cell damaging capacity and EC responses after 6 h of coincubation. (A) Host cell
damage was assessed by lactate dehydrogenase (LDH) measurement. (B and C) Relative normalized expression of cytokine- and chemokine-
encoding genes (B) and the human b-defensin 2 (hBD2)-encoding gene (C) were determined by quantitative PCR (qPCR). The depicted
significance defines the differences between the two fungal treatments. Data were normalized to the uninfected control values (set at equal
to 1). Data were obtained from three independent experiments (n= 3) and analyzed by unpaired t tests. Statistical significance is indicated
by asterisks as follows: *, P , 0.05; **, P , 0.01; ***, P , 0.001; ****, P , 0.0001.
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selected the highest infection dose (MOI of 5:1), which is in accordance with the litera-
ture (31–33).
Next, we investigated the expression of proinflammatory (tumor necrosis factor
alpha [TNF-a], interleukin 1a/b [IL-1a/b], and IL-6) and immunoregulatory (granulo-
cyte-macrophage colony-stimulating factor [GM-CSF]) cytokines, chemokines (IL-8,
ccl2, and ccl20) and an antimicrobial peptide (human b-defensin 2, or hBD-2).
Remarkably, C. albicans elevated the expression of all examined chemokines and cyto-
kines (from 7 to 840 times higher expression) relative to the untreated control (Fig. 1B).
Coculture with C. parapsilosis also resulted in statistically significant differences in cyto-
kine/chemokine responses; however, compared to the exuberant immune response
evoked by C. albicans, these changes were modest (Fig. 1B). For C. parapsilosis, these
included IL-1a (2.216 0.65, P = 0.097), IL-1b (1.656 0.11, P , 0.01), ccl2 (0.526 0.1,
P , 0.01), and CSF2 (3.126 0.53, P , 0.05) relative to the untreated sample’s normal-
ized value of 1. Although not significant, the expression of hBD-2 increased in the pres-
ence of C. albicans only (Fig. 1C). Hence, we found marked differences in the immune
response triggered by the two Candida species. Next, we aimed to examine whether
these distinctive responses were due to alterations in regulatory processes during stim-
ulation with these fungi.
Species-specific host gene and miRNA expression profiles detected for C.
parapsilosis and C. albicans. Transcriptome and miRNA profile analyses were per-
formed to further examine the distinctive responses of the ECs to the two yeast spe-
cies. To obtain analysis-ready count data from the raw sequencing result files, we fol-
lowed the pipeline detailed in Fig. 2A. In addition to the above-mentioned doses for
the two species (MOI of 1:1 for C. albicans and 5:1 for C. parapsilosis), we also applied
the 1:1 dose for C. parapsilosis for the subcellular analyses in order to have an equiva-
lent ratio of host and pathogen for comparisons. Transcripts were analyzed both after
an early (1-h) and a later (6-h) time point of fungal exposure to further examine both
inflammatory, as well as potentially activated non-inflammation-related EC responses.
These data were compared to those of the uninfected controls. Our results indicate
that the majority of host cell responses to both species occurred 6 h after the start of
the coculture, rather than shortly following the initial interactions (Fig. 2B). When com-
paring the MOI 1:1 infection doses of both species at 1 h of coculture, 50 differently
expressed genes (DEGs) were identified with 46 (20 downregulated and 26 upregu-
lated genes) occurring in C. albicans and 4 (all downregulated) in C. parapsilosis-treated
cells. At the 6-h time point, 648 DEGs (348 downregulated and 259 upregulated genes)
were identified in the setting of ECs with C. albicans and 79 (23 downregulated and 56
upregulated genes) with C. parapsilosis. Thus, at both time points, C. parapsilosis treat-
ment effected the expression of a significantly lower number of genes at the MOI of
1:1.
Once the fungal load was increased however (MOI of 5:1), significantly more DEGs
were identified at both times (83 DEGs at 1 h: 23 downregulated and 60 upregulated
genes; 262 DEGs at 6 h: 55 downregulated and 207 upregulated), which exceeded the
number of DEGs identified after C. albicans stimulus at 1 h. During the transcriptome
analysis, we identified genes with species-specific expression and identical genes with
similar or opposite expression patterns when comparing C. albicans and both ratios of
C. parapsilosis (Fig. 2B). The identified DEGs under the different conditions are listed in
Table S1 in the supplemental material.
Next, we examined the ECs’ miRNA profile. miRNA analysis results revealed several
miRNAs that were specifically expressed not only in the presence of the two species
but also specific to the applied doses of C. parapsilosis. We identified 2, 2, and 3 mature
miRNA transcripts at 1 h and 2, 8, and 16 at 6 h of C. parapsilosis MOI 1:1, MOI 5:1, and
C. albicans MOI 1:1 stimulus, respectively (Fig. 2C). While the majority of miRNAs
showed a condition-specific altered expression, miR-4464-3p showed a significantly
increased expression at 1 and 6 h of C. albicans treatment compared to the untreated
control. Of the differentially expressed miRNAs, 1, 2, and 2 target mRNAs were found at
1 h, while 12, 56, and 185 target mRNAs were identified at 6 h of C. parapsilosis MOI 1:1,
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MOI 5:1, and C. albicans MOI 1:1 stimulus, respectively (Tables S2 to S4). These results
suggest that species-specific, and in the case of C. parapsilosis, dose-specific posttran-
scriptional regulatory mechanisms regulate host responses under the applied condi-
tions, which could explain the altered transcriptomic responses.
FIG 2 Differentially expressed genes (DEGs) and dysregulated miRNAs in host responses following fungal stimuli. Host
transcriptomic and miRNA responses were examined with next generation (NGS) sequencing methods (Illumina). (A) Workflow of
raw data analysis, where the obtained sequences were processed alongside the above detailed bioinformatical pipeline via
command line (perl- and java-based) bioinformatical tools (gray boxes), through the listed intermediate files (green/red boxes).
Adapted from “Next Generation Sequencing Data Processing” by BioRender.com (2021). Retrieved from https://app.biorender.com/
biorender-templates. (B) Venn diagrams of host genes identified at 1 and 6 h under each applied condition. The numbers of
condition-specific genes as well as genes regulated by multiple conditions are shown. The term “changed trend” (green) refers to
genes regulated by more than one condition, but the fold change was positive under at least one condition and negative in
another. (C) Differently expressed host miRNA profiles after the applied conditions.
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Carbohydrate metabolism-, hypoxia-, and cardiovascular development-related
responses dominate after C. parapsilosis stimulus, while C. albicans predominantly
induces inflammation responses. Next, we aimed to categorize the identified tran-
scripts and characterize host responses based on the activated host signaling path-
ways. We employed different gene set enrichment analyses (GSEA) and overrepresen-
tation analyses (ORA) methods (Fig. 3A) to examine the modified canonical pathways
(KEGG’s pathway analysis [Fig. 3B]) and biological functions based on gene ontologies
(gene ontology [GO] term analysis [Fig. 3C]). At 1 h after fungal exposure, the responses
detected did not allow for a more in-depth analysis. Therefore, we focused on the 6-h
data set. With C. albicans-treated ECs, both biological pathways and functions were
clearly dominated by inflammatory responses as shown by the 10 most activated path-
ways and functions in Fig. 3B and C. Some of the most significantly regulated pathways
were the cytokine-cytokine receptor interaction, tumor necrosis factor signaling, and
IL-17 signaling pathways, while activated biological functions included inflammatory
responses, responses to bacteria, to molecules of bacterial origin (e.g., lipopolysaccha-
ride [LPS]), and to chemokines (Table S5). In contrast, C. parapsilosis 1:1 infection
resulted in the activation of routes involved in vascular development and, interestingly,
pathways frequently associated with carcinogenesis (e.g., Rap1 and Ras signaling path-
ways, HIF1 and vascular endothelial growth factor [VEGF] signaling pathways). The
affected biological pathways dominantly clustered around vascular development
FIG 3 Results of the KEGG pathways and GO term analyses. (A) The “enrichKEGG” and “enrichGO” functions (provided within the R-package DOSE) and
“CNA” and “URA” analyses (provided within Ingenuity Pathway Analyses methods) were used to analyze the significantly up/downregulated pathways,
functions, and upstream regulatory networks, respectively. (B and C) List of the 10 most activated pathways and functions after each stimuli (B). The KEGG
results were labeled with their respective interest-to-background ratio (x axis on the figures) within the pathways, their significance (color coding) and with
a corresponding “count,” which refers to the number of DEGs within a specific pathway. Ten (or less) significant pathways with the biggest “Gene Ratio”
were visualized as dotplots via the “enrichplot” package. (C) The GO term results were visualized similarly for all the applied conditions. (Created with
BioRender.com.)
Horváth et al.


























































(e.g., vasculature development or angiogenesis) (Table S6). Similar pathways were also
activated by the C. parapsilosis MOI 5:1 coculture, although these were also comple-
mented with activations of carbohydrate metabolic pathways (e.g., starch and glucose
metabolism pathways) and hypoxia-related response routes (e.g., HIF1-a signaling
pathway). Coculture of ECs with C. parapsilosis at an MOI of 5:1 also induced the activa-
tion of a few inflammation-related pathways (e.g., cytokine-cytokine-R interaction
pathway) (Table S7). Thus, while C. albicans triggered multiple inflammation pathways,
C. parapsilosis evoked a variety of mainly inflammation-independent host responses
that have not been previously associated with this species.
Potential effects of species-specific miRNA responses on host cell function. To
examine whether the identified miRNAs could affect the evoked transcriptomic
responses, we first overlapped the targets of the obtained miRNAs and the correspond-
ing altered transcriptomic profiles in each condition. Then, using cluster analyses of GO
overrepresentation tests, we analyzed functions that the potential target mRNAs (or
the target genes of all identified miRNAs per condition) could affect under each condi-
tion. As the early transcriptional responses under all conditions and the later transcrip-
tional responses after C. parapsilosis MOI 1:1 treatment were only mild, none of the
predicted functions passed the set P value threshold. Thus, only the differentially
expressed target mRNAs derived from C. parapsilosis MOI 5:1 and C. albicans MOI 1:1
stimuli were analyzed (Fig. 4A and B). According to the GO term analyses, the top five
target mRNA functions of target mRNA functions after C. albicans challenge were
“response to bacteria,” “regulation of metabolic processes,” “negative regulation of cell
proliferation,” “response to hypoxia,” and “multicellular processes’ (P , 0.0001) (Fig. 4A
and Table S8). These functions were clustered in the following categories: “response to
stimulus,” “metabolic processes,” “cellular processes,” and “developmental processes,”
respectively. With C. parapsilosis coculture, “response to hypoxia,” “positive regulation
of chemotaxis,” “vascular processes,” “positive regulation of migration,” and “monosac-
charide metabolic processes” were listed as the most significantly enriched functions
(P , 0.0001), within the major identified clusters of “response to stimulus,” “cell motil-
ity, “developmental processes,” and “metabolic processes” (Fig. 4B and Table S9).
These data suggest that the identified miRNAs could actively regulate the identified
species-specific transcriptomic responses.
HIF1-a pathway activation results in disrupted glucose metabolism after C.
parapsilosis stimulus and in survival promotion after C. albicans infection. In addi-
tion to the several species-specifically activated signaling pathways, we found two—
HIF1-a and hepatic stellate cell (HSC) activation signaling pathways—that were signifi-
cantly regulated in all three experimental setups at 6 h. Therefore, we examined these
pathways in more depth. In the HIF1-a pathway, the C. parapsilosis MOI 1:1, MOI 5:1,
and C. albicans MOI 1:1 stimuli resulted in the significant up- or downregulation of 7,
11, and 15 genes, respectively. In each case, we found treatment-specific activated
genes as well as genes whose expression altered under at least two conditions (Fig. 5).
The HIF1-a signaling pathway was significantly activated during all three types of stim-
uli compared to the “basal expression” level of the unstimulated cells. The effect was
statistically most significant after the C. parapsilosis 5:1 treatment (P = 3.32e208), fol-
lowed by C. parapsilosis MOI 1:1 (P = 3.99e207) and C. albicans MOI 1:1 (P = 1.19e206)
(Fig. 6A). We next examined potential functions that could be altered with HIF1a path-
way deregulation. A similar activation pattern was observed in three of these biological
processes: cell survival, migration, and angiogenesis. C. albicans clearly activated these
processes (z-scores: 3.781, 3.185, and 3.481 of cell survival, migration, and angiogene-
sis, respectively), while the C. parapsilosis MOI 5:1 treatment resulted in a similar effect,
but activation occurred to a lesser extent (z-scores: 3.060, 2.789, and 3.879, respec-
tively). The C. parapsilosis MOI 1:1 stimulus led to only mild activation or even inhibi-
tion (z-scores of survival, 1.601, of angiogenesis, 0.860, and of migration, 20.19).
Furthermore, extracellular matrix (ECM) synthesis inhibition was a characteristic of C.
albicans treatment, while activation of glucose uptake and metabolism was a unique
effect of the two C. parapsilosis stimuli (Fig. 6B).
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FIG 4 Multidimensional scaling plot of target mRNA functions. Potential effects of condition-specific miRNAs on transcriptomic responses. The potential
functions of target mRNA were analyzed using cluster analyses of GO overrepresentation tests. Top five functions (shown in red) of target mRNAs at 6-h C.
albicans MOI 1:1 treatment (A) and C. parapsilosis MOI 5:1 challenge (B). Gray circles represent the corresponding clusters of each highlighted function.
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FIG 5 Pathway explorer results on HIF1-a signaling in Ingenuity Pathway Analysis (IPA). Significantly down- or overexpressed
genes in each condition were visualized within the canonical HIF1-a signal transduction network using pathway explorer
and designer tools within IPA. The individual genes affected by each treatment were marked by the corresponding colors of
each condition: blue for C. parapsilosis at an MOI of 1:1, purple for an MOI of 5:1, and red for C. albicans at an MOI of 1:1.
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Next, we aimed to examine potential correlations between the results of the transcrip-
tome and miRNA analyses by identifying miRNA-target mRNA pairs. Such pairs were iden-
tified after both C. albicans and C. parapsilosis MOI 5:1 coculture, but none were found for
the C. parapsilosis MOI 1:1 condition (Fig. 6C). For C. albicans-treated ECs, miR-34b (down-
regulation, logarithmic fold change [LFC] = 21.87) and its potential target mRNA, TGF-a
(transforming growth factor alpha; upregulation, LFC=1.758)—a known regulator of cell
proliferation and survival—was identified. Another miRNA-mRNA pair included miR-2110
(LFC = 5.00) and PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3; LFC =22.53). In
the case of C. parapsilosis MOI 5:1-treated ECs, miR-210 (LFC=1.98) and its potential tar-
get CAMK2B (calcium-dependent protein kinase 2 beta; LFC = 22.36) and another
miRNA, miR-92a (LFC = 21.85), were identified. The latter’s potential HIF1-a pathway tar-
get elements include EDN1 (endothelin-1 precursor; LFC = 2.11) and two glucose trans-
porters SLC2A1 (GLUT1; LFC = 2.552) and SLC2A14 (GLUT14; LFC = 3.555) (Fig. 6C).
Interestingly, an overlap could also be observed among the applied conditions in terms
of the expression of specific target genes, but without the targeting miRNAs. This sug-
gests, that under the different conditions, the expression of the examined genes is possi-
bly regulated by other posttranscriptional regulatory processes.
Hepatic fibrosis/stellate cell (HSC) activation pathway discriminates between
the strong and attenuated inflammatory response toward the two species. The
other signaling pathway that was simultaneously regulated by all three conditions af-
ter 6 h was the hepatic fibrosis or hepatic stellate cell (HSC) pathway—a pathway
involved in stellate cell activation during hepatic inflammation and injury. The early
signaling events during the activation of HSCs and in activated HSCs are shown in
Fig. 7. Similar to the HIF1-a pathway, several genes showed either species-specific or
treatment-influenced expression changes (Fig. 7). The regulation of the signal trans-
duction pathway by C. parapsilosis at an MOI of 1:1 and 5:1 and C. albicans at an MOI of
1:1 was also statistically significant, although the direction of change could not be
determined, due to the incoherent changes in gene expression (Fig. 8A). This pathway
is associated with a number of biological functions related to inflammation, cellular
activation, chemotaxis, apoptotic cell death, or tumor cell proliferation. In general, C.
albicans stimuli led to the overall activation of proinflammatory responses (e.g., upreg-
ulation of chemotaxis, cellular activation), while C. parapsilosis treatment resulted in ei-
ther only a mild inflammatory response (e.g., immune cell activation with MOI of 5:1)
or no significant effect (chemotaxis and cellular activation with MOI of 1:1; and inflam-
mation and chemotaxis response for MOI of 5:1). Host cell apoptosis was inhibited by
all three applied fungal conditions, although C. parapsilosis MOI 1:1 elicited the strong-
est inhibitory effect (z-score = 22.059). Interestingly, in contrast to the robust host tu-
mor cell proliferation promoting effect of both C. albicans and C. parapsilosis at an MOI
of 5:1, the low-dose application of C. parapsilosis led to a mild inhibitory effect (z-
score = 2.260, 2.248, and 20.586, respectively) (Fig. 8B).
Similar to the HIF1-a pathway, miRNA-mRNA target pairs could be identified after C.
albicans and C. parapsilosis MOI 5:1 stimulus, but not after the lower C. parapsilosis infec-
tion dose. Four miRNAs with altered expression were identified in C. albicans-treated cells,
namely, miR-2110 (LFC = 5.00), miR-4485 (LFC =22.19), miR-34b (LFC =21.87), miR-4677
(LFC = 21.73), and their potential counterparts included IGFBP5 (insulin-like growth fac-
tor-binding protein 5; LFC = 23.81), KLF6 (kruppel-like factor 6; LFC = 1.58), TGF-a (LFC =
1.76), and IL-8 (chemokine; LFC = 9.90), respectively (Fig. 8C). After C. parapsilosis MOI 5:1
treatment, miR-92a and its potential target (EDN1) as well as miR-543 (LFC = 23.38) and
its potential target IGFBP3 (insulin-like growth factor-binding protein 3; LFC = 4.20) were
identified. Although no regulatory miRNAs were identified after C. parapsilosis MOI 1:1
treatment, we found altered levels of expression of KLF6 and IGFBP5, suggesting that
they were possibly regulated by other posttranscriptional regulatory processes.
In this pathway, each of the targeted genes primarily affect inflammatory functions.
Thus, the miRNA silencing observed here may contribute to the discrimination of the
inflammatory response to C. albicans and C. parapsilosis.
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In this study, we aimed to dissect and compare host responses triggered by C. albi-
cans and C. parapsilosis—two common fungal residents of the oral microbial commu-
nity—in oral ECs derived from a healthy individual (34). Our findings indicate that the
EC immune response is more robust by 6 h of coincubation, by which time both spe-
cies underwent morphology transition, rather than after 1 h, when both C. albicans and
C. parapsilosis are in a yeast form or only initiating their secondary morphology, sug-
gesting that morphology transition could be a key trigger of the epithelial cell
responses. ECs actively discriminate between C. albicans and C. parapsilosis, as shown
FIG 6 Results of the IPA analyses on the HIF1-a signaling-related molecular components and functions. (A) The
significance of the pathway activation and direction were determined by the P value of overlap (,0.05) after
performing an expression core analysis in IPA on the set of DEGs in each applied condition. (B) The direction of
activation of the functions regulated by this signaling pathway was analyzed similarly. The blank (white)
rectangles mean that we could not observe a significant regulation of that particular biological function under
or after the corresponding treatment. (C) We selected the miRNA-mRNA target pairs involved in this signaling
pathway after applying several filtering steps in IPA’s miRNA target filter tools. We only considered pairs that
showed significant, opposite regulation in corresponding treatments, in which the targets were scientifically
proven to be involved in HIF1-a signaling and the target site on the mRNA was either experimentally proven
or strongly predicted by IPA based on base complementarity.
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by the significant differences in host LDH release, chemokine, cytokine, and antimicro-
bial peptide responses. In our model, C. parapsilosis failed to evoke a robust, immediate
proinflammatory response compared to C. albicans, which is similar to what has been
observed in other experimental infection models (35–39). These findings are also com-
parable with earlier studies of Candida-EC interactions, showing that only C. albicans
triggers a strong inflammatory response during the colonization of the oral epithelial
barrier (36). To aid the understanding of how oral ECs might discriminate between the
two species and thus distinguish a species with a higher pathogenic potential from
one that more commonly is a mucosal commensal, we examined host cell transcrip-
tomic changes following yeast-EC interaction.
Our findings revealed significant differences in host cell transcriptomic responses
that were species specific. With C. albicans coculture, the majority of signaling routes
and pathways were specific to the inflammatory response and resulted in the activa-
tion of, e.g., NF-κB and IL-17 signaling pathways (both are required for epithelium
protection during oral candidiasis), which is in line with previous reports (40–42).
C. parapsilosis challenge, however, led to the activation of various, mainly inflamma-
tion-independent pathways, such as carbohydrate metabolism-, hypoxia-, and cardio-
vascular development-related responses, and interestingly, pathways frequently associ-
ated with carcinogenesis, none of which have been previously associated with this
species. The expression of genes related to carbohydrate metabolic processes was also
upregulated in the case of both C. parapsilosis doses. Glucose homeostasis mainte-
nance has recently been suggested to be required for efficient anti-C. albicans immune
FIG 7 Pathway explorer results on hepatic fibrosis/stellate cell activation signaling in IPA. Similar to the HIF1-a signal transduction network, regulated
molecular components were visualized via pathway designer tools.
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responses (43). According to Tucey et al (43), C. albicans depletes glucose from human
and murine macrophages during infection, thereby accelerating host cell death.
Although no studies are available comparing the carbon metabolism of C. albicans and
C. parapsilosis, high glucose tolerance and rapid proliferation of C. parapsilosis in glu-
cose-rich parenteral nutrition have previously been reported (44–46). This suggests
enhanced glucose metabolic processes in this species, and also that during C. parapsi-
losis infections, regulation of host glucose metabolism, as a virulence factor, might be
even more momentous. Although further research is required to confirm this hypothe-
sis, considering that the highest risk group of C. parapsilosis infections includes low-
birth-weight neonates (47), the population primarily receiving parenteral nutrition,
interfering with the pathogen’s carbon metabolic processes might reduce the risk of
invasive candidiasis development in this patient group. Damaged tissues and inflam-
mation are often coupled with local hypoxia (48). The lack of severe host cell damage
and proinflammatory responses upon high-dose C. parapsilosis challenge suggests that
the significantly altered hypoxic responses have other origins. Such responses could
arise simply due to the elevated fungal burden rapidly depleting available oxygen lev-
els through the rapid outgrowth of host cells. Host responses related to cardiovascular
development and the activation of pathways frequently associated with carcinogenesis
during C. parapsilosis treatment are also unique, as no such phenomenon has been
previously associated with this species. Changes of expression in tumorous pathways
FIG 8 Results of the IPA analyses of hepatic fibrosis/stellate cell activation signaling. (A) Direction of activation
of the hepatic fibrosis signaling-related functions were analyzed after an expression core analysis of the DEGs.
(B) Pathway activation was also examined. (C) miRNA-miRNA-targets were analyzed via miRNA target filter tools
under similar conditions.
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were dose dependent, as the low dose of C. parapsilosis treatment (MOI of 1:1) had no
effect on expression of the related pathways, while the high-dose treatment (MOI of
5:1) significantly enhanced singling routes related to carcinogenesis, similar to that
observed with C. albicans treatment (MOI of 1:1). Such novel information sets the
ground for a new aspect of future experimental investigations in the field of Candida
research together with cancer biology.
Besides the species-specific activated pathways, signaling pathways with simultane-
ous regulation by all three conditions were also found. Even among these, condition-
specific transcriptional responses could be identified. One such pathway was hypoxia-
inducible factor 1a (HIF1-a) signaling. HIFs, especially HIF1-a, have previously been
demonstrated to regulate various innate immune processes (49). Although a study
showed that HIF1-a activation by b-glucan and commensal bacteria promotes protec-
tion against subsequent C. albicans infections (50, 51), suggesting the pathway’s inclu-
sion in anti-Candida responses, little is known about its role in antifungal immunity
regulation. Our results suggest that activation of the HIF1-a pathway is divergent.
While C. albicans stimulus promoted signaling processes related to cell survival and
migration, or inhibition of ECM synthesis, glucose uptake and metabolism-related
processes dominated after C. parapsilosis coculture. While regulation of EC protective
cellular responses seems to be a priority in the case of C. albicans, in line with previous
reports (52), regulation of carbohydrate metabolism appears to be a unique character-
istic of C. parapsilosis stimulus. The HSC activation pathway (“hepatic stellate cell acti-
vation pathway”), the other pathway simultaneously activated by all conditions, is not
a singular signaling route in a strict sense, but rather a collection of several extracellu-
lar signaling molecules and their related pathways whose activation altogether lead to
the transformation of stellate cells into proliferative, fibrogenic myofibroblasts under
suitable conditions. These pathways include, for example, TGF-b/SMAD and TGF-
a/EGFR (epidermal growth factor receptor) pathways, which are important participants
in these processes (53). These pathways are also known to influence epithelial cell
functions, including their proliferation and chemotaxis (54, 55). In the HSC activation
pathway, both species regulated signaling processes primarily involved in inflamma-
tion. Although C. albicans challenge resulted in the overall activation of proinflamma-
tory responses, C. parapsilosis coculture led to only a mild effect. Species-specific regu-
lation of both HIF1-a signaling and the HSC activation pathway might be what
determines the outcome of the triggered innate immune responses of oral ECs.
Subsequent miRNA analyses revealed condition-specific posttranscriptional regula-
tion of the transcriptomic responses. Among the identified dysregulated miRNA spe-
cies, 4 were associated with coculturing ECs with C. parapsilosis at an MOI of 1:1, 10
with an MOI of 5:1, and 18 with C. albicans. Among the miRNAs identified during C.
albicans treatment, only miRNA-16-1p has been previously associated with C. albicans
infections (28). Out of the remaining 17 differentially expressed miRNAs, miR-20a and
hsa-let-7 have been reported to regulate antifungal responses, although only in
Paracoccidioides brasiliensis (56). miR-16 and miR-4677 have been linked to antibacte-
rial host responses (57, 58), while miR-3074, miR-335, miR-34b, miR-4485, and miR-
1246 have been associated with antiviral immune responses in various in vitro models
(59–63). The remaining nine identified miRNA species have not yet been associated
with microbe-induced inflammatory responses. In contrast, except for miR-3064 and
miR-1294, all of the miRNAs differentially regulated in the presence of C. parapsilosis
have been suggested to regulate host responses during microbial stimuli. miR-210 was
previously associated with C. albicans (26), miR-125b with P. brasiliensis (64), and miR-
92a with Paracoccidioides americana infections (65). Other than antifungal host
responses, miR-4755 and miR-4677 deregulation was previously linked to bacterial
stimuli (58, 66), miR-1305, miR-627, miR-543, and miR-581 to viral challenge, and miR-
12135 to parasitic infections (67). miR-1277 and miR-365 were associated with host
responses upon both bacterial and viral infections (68–72). Thus, although fewer
miRNA species could be coupled with C. parapsilosis infections than with C. albicans,
Horváth et al.


























































the majority of these were confirmed regulators of antimicrobial responses. It is note-
worthy that several of the miRNAs identified after both C. albicans and C. parapsilosis
stimuli have also been associated with various tumorigenic processes (73–78), further
highlighting that fungal colonization might actively influence tumorigenic processes,
as suggested previously (79, 80).
Subsequent analyses revealed that the yeast-specifically-identified miRNA species
regulate the expression of genes involved in condition-specific activated pathways,
including survival, proliferation, and inflammation in C. albicans and vascular develop-
ment- and carbohydrate metabolism-related pathways in C. parapsilosis cocultures. For
instance, miR-92a was identified in HIF1-a signaling, potentially regulating the expres-
sion of GLUT1 (SLC2A1) and GLUT14 (SLC2A14), two glucose transporters required for
carbohydrate metabolism maintenance (81) as well as the expression of EDN1 (endo-
thelin-1) (82), a potent vasoconstrictor, during C. parapsilosis infection. The finding that
both GLUT1 and GLUT14 are also upregulated upon C. albicans stimulus suggests that
the significant activation of carbohydrate metabolic processes by C. parapsilosis is the
result of an additive effect and that glucose metabolic regulators, other than the men-
tioned glucose transporters, are also deregulated during the stimulus. In the same path-
way, following C. albicans challenge, miR-34b was linked to TGF-a expression, a known
regulator of survival and cell proliferation after its activation by hypoxia-induced factors
(such as HIF1-a) (83), and miR-2110 was found to repress PIK3R3 expression, a subunit of
PI3K, thereby interfering with proinflammatory responses (84, 85).
In the HSC activation pathway, besides miR-92a and its target EDN-1, miR-543 was
also identified, which targets IGFBP3, an IGF-binding protein previously linked to apo-
ptosis regulatory processes (86). Although independent of IGFBP3 expression changes,
apoptosis inhibition as a potential outcome of HSC activation was predicted to be the
strongest following the low-dose C. parapsilosis treatment. With C. albicans infection,
besides the above-mentioned miR-34b2TGF-a pair, miR-2110 was identified as a
potential regulator of IGFBP5, miR-4485 was linked to KLF6 regulation, and miR-467 to
regulating CXCL8 expression. KLF6 is a zinc finger transcription factor previously
reported to promote inflammation in macrophages (87). IGFBP5, another IGF-binding
protein, was reported to be a potent chemoattractant of immune cells (88). CXCL8 is a
well-known chemokine secreted by oral ECs upon C. albicans stimuli (89), in line with
our data. Thus, all three miRNA target genes are potential inflammation regulatory
components of the anti-C. albicans oral EC response.
Taken together, the in-depth analyses of the two simultaneously, yet diversely regu-
lated signaling pathways also support the major, species-specific findings of the tran-
scriptome functional analyses and suggest that the differentiating EC responses might
indeed derive from altered posttranscriptional regulations. Although the obtained
results shed some light on the potential underlying molecular mechanisms enabling
species-specific host responses, further investigations and experimental studies are
required to support these findings, such as by applying various C. albicans and C. para-
psilosis clinical isolates simultaneously, to confirm our findings or further reveal poten-
tial strain-dependent differences, along with applying in vivo experimental setups to
examine these interactions under complex oral environmental conditions.
In summary, we can conclude that human oral ECs are able to actively differentiate
between Candida species through altered posttranscriptional regulatory processes
(Fig. 9). While the presence of C. parapsilosis stimulus does not generate a robust
inflammatory response in ECs, an elevated fungal burden can initiate inflammatory
responses, albeit in a much less rapid and robust manner compared to C. albicans.
Additionally, we found that different fungal burdens of C. parapsilosis led to the vari-
able induction of generic alterations with the higher MOI inducing a broader and more
significant response. The species-specific fine-tuning of both HIF1-a signaling and HSC
activation pathways via miRNA silencing could also be a key to the distinct epithelial
responses. The in silico data acquired through this project aid our current
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understanding of how healthy oral ECs might discriminate between Candida species
with high or low pathogenic potential in the human oral mucosa.
MATERIALS ANDMETHODS
Strains and growth conditions. In this study, Candida parapsilosis CLIB 214 and Candida albicans
SC5314 laboratory strains were used. Candida strains were maintained on solid penicillin-streptomycin-
supplemented YPD medium at 4°C. Prior to host cell stimulation, yeast cells were grown overnight at
30°C in liquid yeast extract-peptone-dextrose (YPD) medium, washed three times with phosphate-buf-
fered saline (PBS), and counted using a hemocytometer to adjust the desired cell concentration.
Stimulation of OKF6/TERT2 cells. The oral EC line OKF6/TERT2, a telomerase-deficient EC line
derived from a healthy individual, was used for all experiments and maintained as described previously
(34). Oral ECs were then plated in six-well plates in keratinocyte serum-free medium (K-SFM) supple-
mented with 25mg/ml bovine pituitary extract (BPE), 2 ng/ml recombinant epidermal growth factor
(rEGF), 2mM L-glutamine, and 0.5% penicillin-streptomycin, and cells were grown to 90% confluence.
OKF6/TERT2 cells were then stimulated with C. parapsilosis and C. albicans in serum-free K-SFM medium.
Depending on the experiment, either cell-free supernatants or host cells were collected following fungal
exposure and stored at 280°C or used immediately.
Lactate dehydrogenase assay. Host cell damage by C. albicans and C. parapsilosis was determined
by lactate dehydrogenase (LDH) cytotoxicity detection kit according to the manufacturer’s instructions.
OKF6/TERT2 cells were challenged with fungal cells at MOIs of 1:5, 1:2, 1:1, 2:1, and 5:1 or left untreated
at various time points. During analysis, the values corresponding to the levels of LDH activity measured
in untreated samples were subtracted from the values of stimulated samples. The percentage of cytotoxicity
was determined as (optical density [OD] of the experimental value/OD of the positive control) 100. 1%
Triton X-100-treated samples served as positive controls. Results are derived from three independent
experiments.
FIG 9 Altered innate immune response regulation in healthy oral ECs discriminate between low-dose C. parapsilosis, increased dose of C.
parapsilosis, and C. albicans stimuli. (Created with BioRender.com.)
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Total RNA and miRNA extraction. Total RNA and miRNA extraction from OKF6/TERT2 cells was car-
ried out with miRNeasy minikits according to the manufacturer’s instructions with minor modifications,
allowing for the simultaneous extraction of total RNA and miRNA. Cells were grown until 90% conflu-
ence in tissue culturing six-well plates in supplemented K-SFM medium, washed once with PBS, and
stimulated with C. albicans (MOI of 1:1) or C. parapsilosis (MOI of 1:1 and/or 5:1) in unsupplemented K-
SFM medium. Following coincubation, host cells were washed two times with PBS and treated with the
supplied QIAzol lysis reagent, avoiding the use of police rubber and extensive vertexing of the samples
to prevent the lysis of fungal cells (hyphae). After host cell lysis, phase separation, and purification of
RNA (both total and miRNA), we performed quantity and quality checks of the samples before proceed-
ing to cDNA library preparation or cDNA synthesis and subsequent sequencing. Three independently
treated biological parallels were used.
cDNA synthesis and real-time PCR analysis. For preliminary expression studies, 1,000 ng of RNA
was utilized for cDNA synthesis using the RevertAid first strand cDNA synthesis kit. Primers for qPCR
analyses are listed in Table S10 in the supplemental material. The amplification conditions were as fol-
lows: one cycle of denaturation for 3min at 95°C; denaturation at 95°C for 10 s; 49 cycles, with 1 cycle
consisting of annealing at 60°C for 30 s and elongation at 65°C for 30 s; and a final extension step at
72°C for 30 s. b2-Microglobulin was used as an internal control. Relative normalized expression values
(unstimulated host cells served as controls) were calculated and presented.
Sequencing library preparation and RNA sequencing. miRNA sequencing libraries were prepared
using NEBNext Multiplex Small RNA Library Prep Set for Illumina following the manufacturer’s protocol.
Libraries were size selected using AMPure XP beads and after validation with an Agilent 2100
Bioanalyzer instrument sequenced with an Illumina MiSeq DNA sequencer using Illumina MiSeq reagent
kit V3-150.
Transcriptome analysis. We performed the preliminary quality analysis and trimming using FastQC
and Cutadapt command line tools on the raw sequence files. Next, we fit the reads to the reference ge-
nome index (GRCh38) using HISAT2 (90), with the parameters –dta –non-deterministic –rna-strandness.
Read numbers were calculated using the GenomicAlignments package, and differential gene expression
in logarithmic fold change (LFC) was then performed using the DeSeq2 tool (91). We filtered out objects
with read counts lower than 1 part per million (ppm). In the experimentally derived gene list, differen-
tially expressed genes (DEGs) were counted above the absolute value of the logarithmic fold change of
.1.5 and the adjusted P value of,0.05.
Short-read mapping and counting. The sequenced reads were mapped to known microRNA precur-
sors, and novel sequences downloaded from miRBase (version 22) using miRDeep2.0 (92). Hits with a read
count below 1ppm were filtered out from further analysis. The distorting effect caused by the hits that were
expressed at an exceptionally high level (and have the largest variance) was corrected via DeSeq2, and the P
value was corrected by null distribution using the fdrtool package. The cutoff values for the significant hits
were set at a P value of,0.05 and the absolute value of the logarithmic fold changeof.1.5.
Overrepresentation analyses. Upon completion of the genome-wide RNA and miRNA expression
analyses, gene expression data were interpreted using overrepresentation analyses (ORA) and gene set enrich-
ment analyses (GSEA) provided in the Bioconductor package, DOSE (93) and clusterProfiler (94) (Fig. 3A). The
two ORAs—KEGG overrepresentation test and GO overrepresentation test—as well as the GO GSEA were car-
ried out, against a constant background, for which purpose, the human genome wide annotation package
(“org.Hs.eg.db”) was used (95). During both analyses, the most robust Benjamini and Hochberg (96) (“BH”)
method was used for the multiple comparison P value adjustment, and pathways P , 0.05 were considered
significantly overrepresented. The enrichment results were visualized as dotplots via the enrichplot package.
For further data mining, we calculated the semantic similarity (SS) of the found GO terms to establish connec-
tions between genes targeted by a specific miRNA via the ViSEAGO package (97). These results were visualized
on a multidimensional scaling plot (MDS) that represents the distance among the set of enriched GO terms on
the first two dimensions, which highlight possible clustering patterns.
Causal analyses. We employed causal analysis methods included in the Qiagen licensed, leading-edge
bioinformatical software Ingenuity Pathway Analysis (IPA), and we ran expression core analyses on our samples.
Among the included algorithms, we used downstream effect analysis (DEA) to observe each treatment’s effect
on the biological functions of the host cells. Furthermore, we concluded miRNA-target analyses to find possible
miRNA-mRNA target pairs with significant, anti-correlated expression. We employed the P value of overlap and
the activation Z-score to determine the significance of the prediction in IPA, which are the two most important
parameters to achieve this (98). The P value of overlap determines the statistical significance based on the
overlap of the observed and predicted regulated gene sets, while the activation Z-score predicts the direction
of regulation depending on the parallelism in the observed and predicted up/downregulatory patterns. In our
experiments, only the predictions with P values of,0.05 were considered significant hits. We further specified
that only experimentally proven or strongly predicted intermolecular relationships should be considered.
Statistical analysis. All statistical analyses were performed with GraphPad Prism v 6.0 software
using parametric t tests or nonparametric Mann-Whitney tests. The values for the groups examined
were considered statistically significantly different at P, 0.05.
Data availability. Sequencing data are accessible under the BioProject accession number PRJNA715092.
SUPPLEMENTAL MATERIAL
Supplemental material is available online only.
TABLE S1, XLSX file, 0.1 MB.
TABLE S2, XLSX file, 0.01 MB.
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